Research.Patient.info
Juvenile Idiopathic Arthritis (JIA) research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingPhase II and Phase III (Integrated)
A3921145 - A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)
This study is looking at the long-term safety and effects of a medicine called tofacitinib for treating juvenile idiopathic arthritis (JIA) in young people. Researchers will check things like growth, overall health, and how well the medicine controls their JIA.
Spain · Belgium · Poland - recruitingPHASE3
OLE Study With Filgotinib in JIA
This study looks at the long-term safety and effects of a medicine called filgotinib in children and young people with arthritis. It's for those who have already seen good results from filgotinib in previous studies.
France · Germany · United Kingdom